COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,300 Articles (22,772 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 3016: Articles 30151-30160  | Next

Computed Tomography Findings and Short-term follow-up with Novel Coronavirus Pneumonia
Qi, S., Guo, H., Shao, H., Lan, S., He, Y., Tiheiran, M., Li, H.
10.1101/2020.04.02.20042614 — Posted: 2020-04-04
Detecting SARS-CoV-2 at point of care: Preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR
Osterdahl, M. F., Lee, K. A., Ni Lochlainn, M., Wilson, S., Douthwaite, S., Horsfall, R., Sheedy, A., Goldenberg, S. D., Stanley, C. J., Spector, T. D., Steves, C.
10.1101/2020.04.01.20047357 — Posted: 2020-04-04
Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients
Herold, T., Jurinovic, V., Arnreich, C., Hellmuth, J. C., Bergwelt-Baildon, M., Klein, M., Weinberger, T.
10.1101/2020.04.01.20047381 — Posted: 2020-04-04 Discussion: Onsite | Offsite
A Mini Review on Current Clinical and Research Findings for Children Suffering from COVID-19
Li, X., Qian, K., Xie, L.-l., Li, X.-j., Cheng, M., Jiang, L., Schuller, B. W.
10.1101/2020.03.30.20044545 — Posted: 2020-04-04
Countrywide quarantine only mildly increased anxiety level during COVID-19 outbreak in China
Hu, W., Su, L., Qiao, J., Zhu, J., Zhou, Y.
10.1101/2020.04.01.20041186 — Posted: 2020-04-04
Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
Yang, G., Tan, Z., Zhou, L., Yang, M., Peng, L., Liu, J., Cai, J., Yang, R., Han, J., Huang, Y., He, S.
10.1101/2020.03.31.20038935 — Posted: 2020-04-04
Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Maitra, A., Hidalgo, M., Dang, C. V.
10.1101/2020.03.31.018556 — Posted: 2020-04-04 Discussion: Onsite | Offsite
In-silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
Periwal, N., Sarma, S., Arora, P., Sood, V.
10.1101/2020.03.31.018499 — Posted: 2020-04-04 Discussion: Onsite
Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
Gritti, G., Raimondi, F., Ripamonti, D., Riva, I., Landi, F., Alborghetti, L., Frigeni, M., Damiani, M., Mico, C., Fagiuoli, S., Cosentini, R., Luca Lorini, F., Fabretti, F., Morgan, J., Owens, B. M. J., Kanhai, K., Cowburn, J., Rizzi, M., Di Marco, F., Rambaldi, A.
10.1101/2020.04.01.20048561 — Posted: 2020-04-03 Discussion: Offsite
Perceptions and behavioural responses of the general public during the COVID-19 pandemic: A cross-sectional survey of UK Adults
Atchison, C. J., Bowman, L., Vrinten, C., Redd, R., Pristera, P., Eaton, J. W., Ward, H.
10.1101/2020.04.01.20050039 — Posted: 2020-04-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).